Literature DB >> 17284925

ACP1 and Th class of immunological disease: evidence of interaction with gender.

F Gloria-Bottini1, N Bottini, G Renzetti, E Bottini.   

Abstract

BACKGROUND: Data collected by our group in the past years indicate a relationship between ACP1 genetic polymorphism and susceptibility/resistance to immunological diseases. Recent observations suggest that through modulation of ZAP-70 activity, the enzyme may influence T cell activation. In view of the current interest in gender differences in autoimmune diseases we reviewed our data to enlighten possible effects of gender on the relationship between ACP1 and class of immunological disease.
METHODS: We studied three samples of subjects with allergic disorders of a total of 299 subjects, 71 subjects with Crohn's disease and 188 children with type 1 diabetes. Three-way contingency tables were analyzed by a log linear model and two-way contingency tables by chi(2) test.
RESULTS: There is an association between ACP1 and allergy (Th2 class) that depends on gender: the presence of the ACP1*A allele seems to make females more susceptible to allergic manifestations as compared to males. ACP1 is also associated with Crohn's disease and type 1 diabetes: the relationship between this class (Th1) of immunological diseases and ACP1 depends on gender. The presence of *A allele seems to make females less susceptible to this class of diseases as compared to males.
CONCLUSIONS: The ACP1*A allele which is associated with low ACP1 activity appears responsible for a complex relationship involving gender, ACP1 and Th1/Th2 orientation. Low ACP1 activity influencing ZAP-70 activity and in turn T cell activation seems to have opposite effects on Th1/Th2 orientation depending on gender.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284925     DOI: 10.1159/000099308

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

1.  Association of ACP1 gene polymorphisms and coronary artery disease in northeast Chinese population.

Authors:  Tianbao Li; Xuesong Xu; Jianzhuo Li; Shu Xing; Lin Zhang; Wannan Li; Junfeng Ma; Xueqi Fu
Journal:  J Genet       Date:  2015-03       Impact factor: 1.166

2.  Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans.

Authors:  Yu-Hsiang Shu; Jaana Hartiala; Anny H Xiang; Enrique Trigo; Jean M Lawrence; Hooman Allayee; Thomas A Buchanan; Nunzio Bottini; Richard M Watanabe
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

3.  Relation between objective measures of atopy and myocardial infarction in the United States.

Authors:  Renee Jaramillo; Richard D Cohn; Patrick W Crockett; Kymberly M Gowdy; Darryl C Zeldin; Michael B Fessler
Journal:  J Allergy Clin Immunol       Date:  2012-08-24       Impact factor: 10.793

Review 4.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

5.  Association between phosphatase related gene variants and coronary artery disease: case-control study and meta-analysis.

Authors:  Xia Han; Lijun Zhang; Zhiqiang Zhang; Zengtang Zhang; Jianchun Wang; Jun Yang; Jiamin Niu
Journal:  Int J Mol Sci       Date:  2014-08-13       Impact factor: 5.923

Review 6.  Regulation of CD4+ T Cell Signaling and Immunological Synapse by Protein Tyrosine Phosphatases: Molecular Mechanisms in Autoimmunity.

Authors:  Patricia Castro-Sánchez; Oscar Aguilar-Sopeña; Sergio Alegre-Gómez; Rocio Ramirez-Munoz; Pedro Roda-Navarro
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

7.  Systematic review reveals multiple sexually antagonistic polymorphisms affecting human disease and complex traits.

Authors:  Jon Alexander Harper; Tim Janicke; Edward H Morrow
Journal:  Evolution       Date:  2021-11-12       Impact factor: 4.171

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.